The role of p14ARF methylation in neuroblastoma minimal residual disease

Erbayraktar Z., Zadeoglulari Z., AKTAŞ S., ELLİDOKUZ H., Kirkali G., Olgun N.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.37, sa.2, ss.129-138, 2012 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 2
  • Basım Tarihi: 2012
  • Doi Numarası: 10.5505/tjb.2012.57966
  • Dergi Adı: TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.129-138
  • Anahtar Kelimeler: Neuroblastoma, p14(ARF) gene, DNA methylation, minimal residual disease, MYELOABLATIVE THERAPY, 13-CIS-RETINOIC ACID, CELL CARCINOMA, TUMOR, TEMOZOLOMIDE, PATHWAY, ARREST, GENE, MYC
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Objectives: The aim of the present study is to investigate the clinical significance of epigenetic changes in neuroblastoma, we evaluated the relationship between therapeutic variables and the pattern of gene methylation in neuroblastoma cell lines.